ScholarIQanswers from OpenAlex

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer

PaperCitations, authors & open-access status

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer have?

ScholarIQcitation count

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer has 589 citations in the OpenAlex counts ScholarIQ stores.

When was Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer published?

ScholarIQyear

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer has 2020 year in the ScholarIQ index.

What is the open-access status of Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer?

ScholarIQoa status

Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer has green oa status in the ScholarIQ index.

What is the DOI of Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer?

ScholarIQdoi

The DOI for Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer is on the source record.

What is the PMID of Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer?

ScholarIQpmid

The PMID for Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer is on the source record.

What is the OpenAlex record for Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer?

ScholarIQopenalex

The OpenAlex for Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial